Drug recall · September 12, 2018
Ethosuximide Capsules recall
Why: Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01
- Lots / codes
Lots: 1165280100, 1165280101, EXP 3/2019
- Quantity
- 23,788 100-count bottles
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide in the USA
- Initiated
- August 24, 2018 · Voluntary: Firm initiated
- Classified
- September 7, 2018
- Reported
- September 12, 2018
- Ended
- November 6, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ethosuximide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.